{"id":19592,"date":"2026-02-10T05:20:28","date_gmt":"2026-02-10T05:20:28","guid":{"rendered":"https:\/\/ivolabs.com\/?post_type=product&p=19592"},"modified":"2026-02-17T02:18:05","modified_gmt":"2026-02-17T02:18:05","slug":"piptapentadol-eu","status":"publish","type":"product","link":"https:\/\/ivolabs.com\/fi\/tuote\/piptapentadol-eu\/","title":{"rendered":"PiPTapentadol EU"},"content":{"rendered":"

PiPTapentadol \u2014 Piperidine-Substituted Tapentadol Analogue (Research Use Only)<\/strong><\/h2>\n

Overview<\/strong><\/h3>\n

PiPTapentadol<\/strong> is a synthetic tapentadol analogue<\/strong> in which the parent molecule\u2019s amine functionality is modified with a piperidine-type (PiP) substitution<\/strong>. This structural change places PiPTapentadol within a niche group of non-phenanthrene, non-fentanyl opioid analogues<\/strong> that are of interest for oikeustoksikologiassa<\/strong>, analytical chemistry<\/strong>, ja structure\u2013activity relationship (SAR)<\/strong> research.<\/p>\n

Unlike classical opioids, tapentadol-based scaffolds are notable for combining \u00b5-opioid receptor (MOR) agonism<\/strong> jossa on norepinephrine reuptake inhibition (NRI)<\/strong>. PiPTapentadol is studied to understand how bulky cyclic amine substitutions influence this dual-mechanism profile, receptor affinity, and analytical detectability.<\/p>\n

\n

Chemical Identity & Structural Characteristics<\/strong><\/h3>\n
    \n
  • \n

    Chemical family:<\/strong> Tapentadol analogues \/ arylalkylamines<\/p>\n<\/li>\n

  • \n

    Core scaffold:<\/strong> 3-(3-hydroxyphenyl)-substituted alkylamine backbone<\/p>\n<\/li>\n

  • \n

    Key modification:<\/strong> Replacement or extension of the amine with a piperidine-based group<\/strong><\/p>\n<\/li>\n

  • \n

    Functional groups:<\/strong> Phenolic hydroxyl, secondary alcohol, tertiary amine<\/p>\n<\/li>\n

  • \n

    Appearance:<\/strong> White to off-white solid (research grade)<\/p>\n<\/li>\n

  • \n

    Puhtaus:<\/strong> Typically \u226598% (analytical standard)<\/p>\n<\/li>\n<\/ul>\n

    The piperidine substitution<\/strong> increases molecular bulk and may affect lipophilicity, metabolic pathways, and receptor orientation when compared to tapentadol itself.<\/p>\n

    \n

    Mechanistic Profile (Class-Based Interpretation)<\/strong><\/h3>\n

    Direct pharmacological data on PiPTapentadol are not publicly available. Based on close structural analogy to tapentadol, the compound is presumed to exhibit:<\/p>\n

      \n
    • \n

      \u00b5-opioid receptor agonism<\/strong>, producing opioid-type signaling<\/p>\n<\/li>\n

    • \n

      Norepinephrine reuptake inhibition<\/strong>, contributing to noradrenergic modulation<\/p>\n<\/li>\n

    • \n

      Minimal serotonergic activity relative to tramadol-type compounds<\/p>\n<\/li>\n<\/ul>\n

      This dual-action hypothesis makes PiPTapentadol relevant for comparative SAR studies<\/strong> exploring how amine substitution alters MOR\/NRI balance.<\/p>\n

      \n

      Pharmacological & Toxicological Considerations<\/strong><\/h3>\n

      As with all novel opioid analogues, PiPTapentadol must be treated as high-risk<\/strong> due to unknown potency and safety margins.<\/p>\n

      Predicted risks (by class inference):<\/strong><\/p>\n

        \n
      • \n

        Respiratory depression<\/p>\n<\/li>\n

      • \n

        CNS depression and sedation<\/p>\n<\/li>\n

      • \n

        Narrow margin between active and toxic exposure<\/p>\n<\/li>\n

      • \n

        Potential for cumulative effects due to lipophilicity<\/p>\n<\/li>\n<\/ul>\n

        No human dosing, safety, or pharmacokinetic data exist. All handling must assume opioid-level hazard<\/strong>.<\/p>\n

        \n

        Laboratory Safety & Handling<\/strong><\/h3>\n

        PiPTapentadol is intended only for controlled laboratory environments<\/strong>.<\/p>\n

        Recommended practices:<\/p>\n

          \n
        • \n

          Handle exclusively in certified fume hoods<\/p>\n<\/li>\n

        • \n

          Use PPE: gloves, eye protection, respiratory protection during weighing<\/p>\n<\/li>\n

        • \n

          Employ microgram-precision balances or volumetric solutions<\/p>\n<\/li>\n

        • \n

          Avoid aerosol formation and cross-contamination<\/p>\n<\/li>\n

        • \n

          Store securely with controlled access<\/p>\n<\/li>\n

        • \n

          Dispose of waste under opioid-class hazardous chemical protocols<\/p>\n<\/li>\n<\/ul>\n

          Not for in vivo use. Not for human or veterinary consumption.<\/strong><\/p>\n

          \n

          Analytical & Forensic Applications<\/strong><\/h3>\n

          PiPTapentadol is suitable for:<\/p>\n

            \n
          • \n

            LC\u2013MS\/MS and GC\u2013MS method development<\/strong><\/p>\n<\/li>\n

          • \n

            Opioid screening panel expansion<\/strong><\/p>\n<\/li>\n

          • \n

            Metabolite and fragmentation pathway studies<\/strong><\/p>\n<\/li>\n

          • \n

            SAR research<\/strong> on tapentadol-derived opioids<\/p>\n<\/li>\n

          • \n

            Forensic casework<\/strong> involving uncommon synthetic opioids<\/p>\n<\/li>\n<\/ul>\n

            Its modified amine structure provides distinct chromatographic retention and MS fragmentation<\/strong>, aiding differentiation from tapentadol and related compounds.<\/p>\n

            \n

            Regulatory Context<\/strong><\/h3>\n

            PiPTapentadol is not an approved pharmaceutical<\/strong>. Depending on jurisdiction, it may be regulated under:<\/p>\n

              \n
            • \n

              Opioid analogue legislation<\/p>\n<\/li>\n

            • \n

              Novel psychoactive substance (NPS) frameworks<\/p>\n<\/li>\n

            • \n

              Broad controlled-substance acts<\/p>\n<\/li>\n<\/ul>\n

              Laboratories must ensure full legal compliance<\/strong> prior to acquisition or use.<\/p>\n

              \n

              Summary<\/strong><\/h3>\n

              PiPTapentadol<\/strong> is a piperidine-substituted tapentadol analogue<\/strong> used as a research reference material<\/strong> in forensic toxicology and analytical chemistry. Its structural divergence from the parent drug makes it valuable for SAR investigations, while its opioid nature demands strict laboratory controls<\/strong> and professional handling.<\/p>\n

              For research use only.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

              PiPTapentadol \u2013 tapentadolijohdannaisen tutkimusstandardi<\/h2>\n

              PiPTapentadol<\/strong> on piperidiinilla substituoitu tapentadolijohdannainen, jota tutkitaan oikeustoksikologiassa<\/strong> ja analyyttisess\u00e4 tutkimuksessa<\/strong>.
              \nIt supports SAR investigations and LC\u2013MS\/MS method development involving non-fentanyl synthetic opioids.<\/p>\n

                \n
              • Tapentadolista johdettu opioidirunko<\/li>\n
              • Erillinen analyyttinen ja fragmentoitumisprofiili<\/li>\n
              • Rajoitettu valvottuun laboratoriok\u00e4ytt\u00f6\u00f6n<\/li>\n<\/ul>\n

                Vain tutkimus- ja analyyttiseen k\u00e4ytt\u00f6\u00f6n. Ei tarkoitettu ihmis- tai el\u00e4ink\u00e4ytt\u00f6\u00f6n.<\/em><\/p>\n

                T\u00e4m\u00e4, kuten kaikki EU RC:n tuotteet, l\u00e4hetet\u00e4\u00e4n pikapostilla ilman seurantanumeroa,
                \nAINOASTAAN Euroopan maihin.<\/strong><\/p>\n

                 <\/p>","protected":false},"featured_media":19598,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[164,180],"product_tag":[1201,1205,1173,1186,1199,1163,1208,1200,1198,1207,1206,1203,1182,1204,1196,1194,1176,1197,1195,1202],"class_list":["post-19592","product","type-product","status-publish","has-post-thumbnail","product_cat-europe-stock","product_cat-benzo-opioid","product_tag-analytical-opioid-compound","product_tag-arylalkylamine-opioid","product_tag-controlled-lab-opioid-compound","product_tag-designer-opioid-analogue","product_tag-forensic-toxicology-reference","product_tag-gc-ms-opioid-calibration","product_tag-laboratory-opioid-standard","product_tag-lc-ms-ms-opioid-standard","product_tag-non-fentanyl-opioid","product_tag-nps-opioid-research","product_tag-opioid-analytical-reference","product_tag-opioid-metabolism-study","product_tag-opioid-sar-research","product_tag-opioid-screening-library","product_tag-piperidine-opioid-analogue","product_tag-piptapentadol","product_tag-research-only-opioid-substance","product_tag-synthetic-opioid-research","product_tag-tapentadol-analogue","product_tag-tapentadol-derivative-research","first","instock","shipping-taxable","purchasable","product-type-variable"],"_links":{"self":[{"href":"https:\/\/ivolabs.com\/fi\/wp-json\/wp\/v2\/product\/19592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ivolabs.com\/fi\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/ivolabs.com\/fi\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/ivolabs.com\/fi\/wp-json\/wp\/v2\/comments?post=19592"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ivolabs.com\/fi\/wp-json\/wp\/v2\/media\/19598"}],"wp:attachment":[{"href":"https:\/\/ivolabs.com\/fi\/wp-json\/wp\/v2\/media?parent=19592"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/ivolabs.com\/fi\/wp-json\/wp\/v2\/product_brand?post=19592"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/ivolabs.com\/fi\/wp-json\/wp\/v2\/product_cat?post=19592"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/ivolabs.com\/fi\/wp-json\/wp\/v2\/product_tag?post=19592"}],"curies":[{"name":"hp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}